Search Tag: clinical trials
2024 14 Mar
Grant to support IND-enabling toxicology and Phase 1/1b development of novel cardiac-safe ibogaine analog, GM-3009 Gilgamesh Pharmaceuticals, a clinical-stage neuroscience company committed to developing best-in-class, rapid-acting treatments for mental health disorders, today announced that it has been awarded a multi-year $14 million grant...Read more
2019 29 Aug
ESC Congress is the world’s largest gathering of cardiovascular professionals contributing to global awareness of the latest clinical trials and breakthrough discoveries. ESC Congress 2019 together with the World Congress of Cardiology takes place from 31 August to 4 September at the Expo Porte de Versailles in Paris, France. The ESC Congress...Read more
2019 10 Apr
A new analysis suggests that women are under-represented in landmark heart failure clinical trials. In the PARADIGM-HF trial, the use of sacubitril-valsartan reduced heart failure hospitalisations as well as cardiovascular death by 20% compared to enalapril. However, only 21% of the study participants were women. In the inclusion criteria for the...Read more
2018 04 Jul
Heart failure (HF) is almost as common in women as men, but its characteristics vary by sex. Of note, women are largely underrepresented in clinical trials of HF medications, and that evidence of medications’ efficacy in women is limited, according to a review article in the journal ESC Heart Failure. Heart failure presentation differs between...Read more
2015 02 Sep
The ESC Congress this year broke all previous records in attendance with nearly 32,773 registrations. Delegates from all over the world attended the Congress this year, bringing forth the latest medical research and the most advanced updates in the field of Cardiology. As pointed out by ESC President, Professor Fausto Pinto, from Portugal. 40 percent...Read more
2014 17 Aug
Over the past decade several scientists have suggested that adrenaline, used for more than fifty years as a key part of resuscitation, may actually do more harm than good. This is based on the evidence that adrenaline may damage the brain by reducing blood supply to the head and may in fact diminish the patient's chances of survival. This is a definite...Read more